NovoLog (insulin aspart) stays active in your system for 3 to 5 hours after a subcutaneous injection. It starts working in about 15 to 20 minutes, hits its strongest blood-sugar-lowering effect between 1 and 3 hours, and then tapers off. The insulin itself is eliminated from your bloodstream with a half-life of roughly 81 minutes, meaning most of it is gone within a few hours.
NovoLog’s Timeline in Your Body
After you inject NovoLog, here’s approximately what happens:
- Onset: Blood sugar starts dropping within about 15 to 20 minutes.
- Peak effect: The strongest glucose-lowering activity hits between 1 and 3 hours. Insulin levels in the blood typically peak around 40 to 50 minutes after injection.
- Duration: The total glucose-lowering effect lasts 3 to 5 hours, then fades.
That 3-to-5-hour window is the one that matters most for daily life. It’s the period where NovoLog is actively pulling sugar out of your bloodstream and the period where you’re at risk for low blood sugar if you’ve taken too much or haven’t eaten enough. After that window closes, the insulin is functionally done working, even if trace amounts are still being cleared from your body.
For comparison, regular human insulin peaks later (80 to 120 minutes to reach maximum blood concentration versus 40 to 50 for NovoLog) and has a longer half-life of about 141 minutes. That’s why NovoLog is categorized as rapid-acting: it hits faster and clears sooner.
Larger Doses Last Longer
The 3-to-5-hour range isn’t a single fixed number because dose size matters. A study comparing 6, 12, and 24 units of insulin aspart in healthy subjects found that metabolic activity, peak insulin levels, and total insulin exposure all increased in a straight line with dose. NovoLog consistently had a shorter duration than regular insulin at every dose tested, but a larger dose will push you closer to that 5-hour end of the range. A small correction dose of a few units will clear faster than a large mealtime bolus.
This is important if you use a pump or take multiple injections per day. Your body isn’t done processing a 15-unit dose in the same timeframe as a 4-unit dose, even though both are the same insulin.
Where You Inject Changes How Fast It Works
Injection site has a real impact on how quickly NovoLog enters your bloodstream. The abdomen absorbs insulin faster than any other common site. In studies, abdominal injections produced higher peak insulin levels and reached those peaks in less than half the time compared to the thigh. The upper arm (deltoid) falls somewhere in between, and the thigh and buttocks are the slowest.
Because you want mealtime insulin to act quickly and match the rise in blood sugar from food, the abdomen is the preferred injection site for NovoLog. If you rotate injection sites between your stomach and your thigh from day to day, you may notice slightly different timing in how the insulin kicks in. That’s not the insulin being inconsistent. It’s the absorption speed at each site being different.
Why the 4-Hour Window Matters for Dosing
One of the biggest practical risks with rapid-acting insulin is something called insulin stacking. This happens when you take a second dose before the first one has finished working, causing the effects to overlap and your blood sugar to drop dangerously low. Because NovoLog’s activity extends up to 5 hours, taking another dose within 3 or 4 hours means you still have “insulin on board” from the previous injection.
Many insulin pumps and glucose management apps track active insulin for exactly this reason, typically using a 4-hour window based on NovoLog’s known activity profile. If you’re dosing manually with a pen or syringe, keep this window in mind before correcting a high reading shortly after a meal. The insulin you already took may not have peaked yet.
Kidney and Liver Problems Don’t Change the Timeline
If you have kidney disease, liver impairment, or a high BMI, you might wonder whether NovoLog lingers longer in your system. Research published in the British Journal of Clinical Pharmacology looked specifically at this question and found no clinically significant changes. Insulin aspart’s pharmacokinetics didn’t correlate with kidney function (measured by creatinine clearance) or liver function (measured by standard liver scoring). This means the 3-to-5-hour duration holds regardless of these conditions.
That said, kidney and liver problems can affect your overall blood sugar regulation and your sensitivity to insulin, even if they don’t change how fast NovoLog itself is eliminated. Your insulin needs may still be different from someone without those conditions.
NovoLog vs. Fiasp: A Faster Version
Fiasp is a newer formulation that contains the same insulin aspart molecule as NovoLog but adds niacinamide to speed up absorption. The practical difference is at the front end: Fiasp can be injected at the start of a meal or even up to 20 minutes after you start eating, while NovoLog should be injected 5 to 10 minutes before. Once absorbed, both have the same 3-to-5-hour total duration. If your main concern is how long insulin stays active in your body, switching between the two won’t change that. The difference is in how quickly the clock starts ticking.